MedTrace Logo

Bleeding In Thrombocytopenia Explained

NCT03505086 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2023-12-21

No results posted yet for this study

Summary

Multicenter case cohort study investigating clinical risk factors for clinically relevant bleeding in hemato-oncology patients, as well as bleeding related biomarkers during intensive treatment.

Conditions

Interventions

DIAGNOSTIC_TEST

Blood withdrawal

* Blood withdrawal will be at regular sampling moments, blood can be collected from a central venous catheter or venepuncture procedure. * Blood withdrawal will be performed for a maximum of 10 times per admission, 10 ml per time. * Urine sampling will be for a maximum of 5 times per admission. * Urine can be sampled from a catheter when present, or collected regular.

OTHER

Questionnaire for former bleeding events

Questionnaire to investigate a bleeding tendency before diagnosis.

Sponsors & Collaborators

  • Sanquin-LUMC J.J van Rood Center for Clinical Transfusion Research

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-04
Primary Completion
2022-10-01
Completion
2026-06-01

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03505086 on ClinicalTrials.gov